1. Considered and approved Audited Financial Results for the Quarter and Financial Year ended 31st March, 2025 along with the along with the Auditors Report thereon, Statement of Assets and Liabilities, and Cash Flow Statement.; 2. Other routine businesses with the permission of Chair.

pdf

Choksi Laboratories Ltd.

31 May 2025

190.15

-1.98%

Board Meeting

Choksi Laboratories Ltd - 526546 - Board Meeting Intimation for Meeting Of Board Of Directors To …

BSE India

Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/06/2025 ,inter alia, to consider and approve 1. To consider and approve the standalone Audited Financial Result of the Company for the fourth Quarter and Year ended on 31st March 2025; 2. 2Any other item may be taken up for consideration with the permission of the Chairman and with the consent of a majority of the Directors present in the Meeting, which shall include at least one independent Director. If any.

pdf

Choksi Laboratories Ltd.

29 May 2025

190.15

-1.98%

Company Update

Choksi Laboratories Ltd - 526546 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report as per Regulation 24 A of SEBI (LODR) 2015 has been attached herewith.

pdf

Choksi Laboratories Ltd.

29 May 2025

190.15

-1.98%

Board Meeting

Choksi Laboratories Ltd - 526546 - Board Meeting Outcome for Outcome Of Board Meeting Dated 29Th …

BSE India

1. Considered and approved the Annual Secretarial Compliance Report for the year ended 31st March, 2025 as required under Regulation 24A of SEBI (LODR) 2015; 2. Other routine businesses with the permission of Chair.

pdf

Choksi Laboratories Ltd.

22 May 2025

190.15

-1.98%

Company Update

Choksi Laboratories Ltd - 526546 - Intimation Under Regulation 30 Of SEBI (LODR) 2015

BSE India

An Intimation under Regulation 30 of SEBI (LODR), 2015

pdf

Choksi Laboratories Ltd.

20 May 2025

190.15

-1.98%

Board Meeting

Choksi Laboratories Ltd - 526546 - Board Meeting Intimation for Meeting Of Board Of Directors To …

BSE India

Choksi Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. To consider and approve the standalone Audited Financial Results for the quarter and year ended 31st March, 2025. 2. Any Other Business.

pdf

Choksi Laboratories Ltd.

25 Apr 2025

190.15

-1.98%

Corp. Note

Choksi Laboratories Ltd - 526546 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyChoksi Laboratories Ltd 2CIN NO.L85195MP1993PLC007471 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 28.13 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Prakhar Dubey Designation: Company Secretary and Compliance Officer EmailId: compliance_officer@choksilab.com Name of the Chief Financial Officer: Vyangesh Choksi Designation: Chief Financial Officer EmailId: v.choksi@choksilab.com Date: 25/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Choksi Laboratories Ltd. worth buying?

8 Votes:

Buy 37.5%

Sell 25.0%

Hold 37.5%